Scarica l'app Stockscreener
26.53
3.49%
-0.96
Pre-mercato:
26.58
0.05
+0.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IMVT Giù?
Forum
Previsione
Immunovant Inc Borsa (IMVT) Ultime notizie
Immunovant Inc stock (US45258Q1058): earnings countdown and biotech hopes raise volatility - AD HOC NEWS
Immunovant stock (US45258Q1058): investors eye upcoming earnings date and autoimmune pipeline - AD HOC NEWS
David Einhorn's Immunovant Inc(IMVT) Holding History - GuruFocus
TradingKey - TradingKey
How (IMVT) Movements Inform Risk Allocation Models - Stock Traders Daily
Alto Neuroscience, Immunovant and other big stocks moving lower in Thursday's pre-market session - MSN
Immunovant stock hits 52-week high of $30.1 - Investing.com India
Immunovant stock hits 52-week high of $30.1 By Investing.com - Investing.com South Africa
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026 - The Manila Times
700,464 Shares in Immunovant, Inc. $IMVT Bought by Jennison Associates LLC - MarketBeat
Immunovant, Inc. $IMVT Shares Sold by Pictet Asset Management Holding SA - MarketBeat
Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Trading Systems Reacting to (IMVT) Volatility - Stock Traders Daily
Immunovant's treatment for eye disease fails in late-stage trials - MSN
Immunovant director Robert Susman sells $67,979 in stock By Investing.com - Investing.com Nigeria
Immunovant director Robert Susman sells $67,979 in stock - Investing.com
Immunovant (IMVT) director’s 10b5-1 sale leaves 36,394 shares held - Stock Titan
Immunovant | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
[144] Immunovant, Inc. SEC Filing - Stock Titan
Immunovant falls on late-stage trial setback for TED therapy - MSN
Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $45 - Moomoo
Wall Street analysts predict a 55.04% upside in Immunovant (IMVT): Here's what you should know - MSN
Immunovant CFO Tiago Girao sells $763,011 in company stock By Investing.com - Investing.com Australia
Immunovant (NASDAQ:IMVT) CFO Tiago Girao Sells 25,760 Shares - MarketBeat
Immunovant (NASDAQ:IMVT) CTO Sells $81,573.48 in Stock - MarketBeat
Immunovant CFO Tiago Girao sells $763,011 in company stock - Investing.com
Immunovant (IMVT) CFO sells 25,760 shares to cover RSU tax - Stock Titan
Immunovant (IMVT) CTO sells 2,754 shares in tax sell-to-cover - Stock Titan
Immunovant (IMVT) Innovation Pipeline | Immunovant posts 16.3% EPS beat on narrower lossRating Downgrade - Cổng thông tin điện tử tỉnh Lào Cai
Immunovant (NASDAQ:IMVT) Sets New 12-Month HighHere's What Happened - MarketBeat
How Immunovant Inc. (IMVT) Affects Rotational Strategy Timing - Stock Traders Daily
Immunovant Inc stock (US45258Q1058): Is its autoimmune pipeline strong enough to unlock new upside? - AD HOC NEWS
Immunovant: Best-In-Class Ambitions, Still Unproven (NASDAQ:IMVT) - Seeking Alpha
Immunovant Inc stock (US45258Q1058): Is its autoimmune pipeline strong enough to unlock biotech upsi - AD HOC NEWS
Immunovant (NASDAQ:IMVT) Reaches New 12-Month HighShould You Buy? - MarketBeat
Immunovant stock hits 52-week high at 29.26 USD By Investing.com - Investing.com Australia
Immunovant stock hits 52-week high at 29.26 USD - Investing.com
2.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):